SEC Info - Caladrius Biosciences, Inc. - ‘8-K’ for 11/18/19

SEC Info℠

Home

Help

Please Sign In

Caladrius Biosciences, Inc. – ‘8-K’ for 11/18/19

On: Monday, 11/18/19, at 6:21am ET · For: 11/18/19 · Accession #: 320017-19-91 · File #: 1-33650

  As Of               Filer                 Filing    For·On·As Docs:Size

11/18/19  Caladrius Biosciences, Inc.       8-K:7,9    11/18/19    3:5.3M

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     16K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     18K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     30K

Filing Submission 0000320017-19-000091 – SGML Text

Original SGML Text submitted by:	Lisata Therapeutics, Inc. [ formerly Caladrius Biosciences, Inc. ]

To view the SGML, please refresh
this page.

↑Top

Caladrius Biosciences, Inc. – ‘8-K’ for 11/18/19

On: Monday, 11/18/19, at 6:21am ET · For: 11/18/19 · Accession #: 320017-19-91 · File #: 1-33650

Previous ‘8-K’: ‘8-K’ on / for 11/6/19 · Next: ‘8-K’ on / for 3/5/20 · Latest: ‘8-K’ on 4/17/24 for 4/15/24

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.